Aortic valve disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who developed a new block during or 1 month after the TAVR operation (lasting more than 30 minutes or during the operation lasting until the end of the TAVR operation) met any of the following criteria and signed an informed consent to participate in the follow-up: 1. Third degree AVB occurred during TAVR procedure or within 1 month after TAVR; 2. Second degree type II AVB occurred during TAVR procedure or within 1 month after TAVR; 3. Second degree type I AVB occurred during TAVR procedure or within 1 month after TAVR; 4. First degree AVB (PR interval>300ms) occurred during TAVR procedure or within 1 month after TAVR with symptoms (Fatigue, dizziness, etc.); 5. Alternating bundle branch block occurred during TAVR procedure or within 1 month after TAVR; 6. Bifascicular block with syncope/blackness related symptoms occurred during TAVR procedure or within 1 month after TAVR.
Exclusion criteria
Exclusion criteria: 1. Permanent pacemaker was implanted before TAVR; 2. TAVR has indications of permanent pacemaker implantation before operation; 3. Conduction block caused by other diseases (such as neuromuscular disorders); 4. Patients had poor compliance and could not complete the study as required.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate PPM implantation at 6 month after TAVR; | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of PPM implantation at 1 month after TAVR; | — |
Countries
China
Contacts
Beijing Anzhen Hospital, Capital Medical University